Medical Device & Diagnostic Imaging Equipment

Medical Device Manufacturers

The U.S. represents 49% of the nearly $500 billion global medical device and diagnostic imaging market according to the U.S. Department of Commerce.  The industry is driven by technological advancement and is heavily regulated by the Food and Drug Administration (FDA), the European Union Medical Device Directive, and other international quality and manufacturing agencies.

Capitalizing on the U.S. Opportunity within the Global Market

Value and Size of the Medical Imaging Equipment Market

Life Science Intelligence reports that the global medical device and diagnostics market is expected to grow at 4.6% cumulative annual growth rate from 2017-2022 to $517 billion. Additionally, Medtech Insight reported that approximately 370 million noninvasive and minimally invasive imaging procedures were performed in the United States (U.S.) utilizing noninvasive and minimally invasive imaging tools. These tools are widely employed for screening, diagnostics, treatment planning, and therapy monitoring in virtually all areas of medicine including: cardiology, emergency medicine, gastroenterology, neurology, obstetrics/gynecology, oncology, orthopedics and spine, pulmonology, trauma, and urology.

Early Cancer Detection and Prevention Technologies

Cancer is the second-leading cause of death in the U.S. after heart disease.  In 2017 it was estimated that nearly 1.7 million people in the country were diagnosed with cancer and that approximately 600,920 died from the disease in the same year. With the American Cancer Society (ACS) sighting breast cancer as the most common cancer among women (excluding non-melanoma skin cancers), this type of cancer accounts for more than 1 in 4 cancers diagnosed in United States (U.S.) women. However, due to the increased awareness, availability, and adoption of highly effective breast cancer screening technologies, the average 5-year relative survival rate for early stage, localized breast cancer now approaches 100%, emphasizing the importance of early breast cancer detection and diagnosis.

As the population continues to age and the number of new breast cancer cases increases, the renewed importance on lowering healthcare costs will result in increased utilization of cost-effective, accurate, early cancer detection and prevention technologies. Next-generation imaging technologies that help lower the number of unnecessary biopsies while allowing for earlier detection with increased sensitivity and specificity over conventional mammography will be willingly adopted, and minimally invasive biopsy and genetic testing will continue to flourish. Minimally invasive biopsy systems will be increasingly preferred over open biopsy due to the ability to lessen patient disfigurement and pain.

Medical Device and Diagnostic Imaging Equipment Industry Participants

Company Sales Employees Location
Cardinal Health, Inc. 102,531.00M 34,500 Dublin, OH
Johnson & Johnson 74,331.00M 126,500 New Brunswick, NJ
Novartis Corporation 58,906.38M 30,186 New York, NY
3M Company 31,821.00M 89,800 St. Paul, MN
Abbott Laboratories 20,247.00M 77,000 Abbott Park, IL
Danaher Corporation 19,913.80M 71,000 Washington, DC
Kimberly-Clark 19,724.00M 43,000 Irving, TX
Medtronic, Inc. 13,379.49M 49,000 Minneapolis, MN
Fresenius Medical Care R 10,373.23M 18,500 Waltham, MA
Stryker Corporation 9,675.00M 26,000 Portage, MI
Becton, Dickinson and Company 8,446.00M 30,619 Franklin Lakes, NJ
Boston Scientific Corporation 7,380.00M 24,000 Marlborough, MA
Allergan, Inc. 7,237.90M 10,500 Irvine, CA
St. Jude Medical, Inc. 5,622.00M 16,000 Saint Paul, MN
Philips Electronics North America 5,118.74M 24,000 Andover, MA
Medline Industries, Inc. 5,100.00M 12,000 Mundelein, IL
Covidien LP 4,742.19M 20,300 Mansfield, MA
Zimmer Biomet Holdings, Inc. 4,673.30M 10,000 Warsaw, IN
Smith & Nephew, Inc. 4,617.00M 14,242 Andover, MA
Hospira, Inc. 4,463.70M 19,000 Lake Forest, IL
Medical Device Manufacturers USA
Hoover’s™/D&B subsidiary First Research® lists the following North American industry participants

 

 

How Can We Help?

Whether you’re evaluating expansion into America or have an established presence, we are available to discuss your current operations and plans for strategic growth in the medical device and diagnostic imaging equipment market. With experience and expertise driving the execution of your strategy, you’ll be on the fastest track to growth and profitability.

Claymount case study - Alliance Technologies
Case Study Claymount

Netherlands-based manufacturer leverages buy and build strategy to expand global footprint into the United States.

 

Read Case Study

Interested to Learn More?

By submitting this form, you consent to allow Alliance Technologies to store and process the data submitted. Read the Full Privacy Policy.